US Patent 9782409 Treatment of cancer and benign proliferative disorders
Patent 9782409 was granted and assigned to The University of Manchester on October, 2017 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 9782409 Treatment of cancer and benign proliferative disorders
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.